Skip to main content

LATEST NEWS

26 Jul | 2024

EMA issues negative opinion on marketing authorisation for lecanemab in Europe

This is the first drug approved by the US regulatory agency through the traditional route that intervenes in the progression of the disease.

Read more
25 Jul | 2024

Müge Akıncı receives her PhD with a research on markers for the identification of preclinical Alzheimer's disease

The work focuses on the role of pathophysiological processes beyond amyloidosis and tauopathy, and modifiable risk factors in the early development of Alzheimer’s disease during its preclinical stage.

Read more

Latest Tweets

Customized integral service for research projects with cerebral magnetic resonance imaging

NEUROIMAGING PLATFORM

Customized integral service for research projects with cerebral magnetic resonance imaging